142 related articles for article (PubMed ID: 34219146)
1. Corruption: An Impediment to Delivering Pathology and Laboratory Services in Resource-Limited Settings.
Glynn EH; Amukele T; Vian T
Am J Clin Pathol; 2021 Nov; 156(6):958-968. PubMed ID: 34219146
[TBL] [Abstract][Full Text] [Related]
2. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
[TBL] [Abstract][Full Text] [Related]
3. Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.
Onwujekwe O; Agwu P; Orjiakor C; McKee M; Hutchinson E; Mbachu C; Odii A; Ogbozor P; Obi U; Ichoku H; Balabanova D
Health Policy Plan; 2019 Sep; 34(7):529-543. PubMed ID: 31377775
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the role of informal payments in the delivery of pathology and clinical laboratory services.
Glynn EH; Amukele T; Soge O; Baird G; Vian T
Am J Clin Pathol; 2024 Jun; 161(6):561-569. PubMed ID: 38345305
[TBL] [Abstract][Full Text] [Related]
5. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
Vian T
Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
[No Abstract] [Full Text] [Related]
6. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
[TBL] [Abstract][Full Text] [Related]
7. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.
Kirya MT
Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012
[No Abstract] [Full Text] [Related]
8. Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in Uganda.
Bouchard M; Kohler JC; Orbinski J; Howard A
BMC Int Health Hum Rights; 2012 May; 12():5. PubMed ID: 22554349
[TBL] [Abstract][Full Text] [Related]
9. Exploring corruption in the South African health sector.
Rispel LC; de Jager P; Fonn S
Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
[TBL] [Abstract][Full Text] [Related]
10. The sustainable development goals as a framework to combat health-sector corruption.
Mackey TK; Vian T; Kohler J
Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
[TBL] [Abstract][Full Text] [Related]
11. Corruption in the health sector: A problem in need of a systems-thinking approach.
Glynn EH
Front Public Health; 2022; 10():910073. PubMed ID: 36091569
[TBL] [Abstract][Full Text] [Related]
12. Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action.
Horton S; Sullivan R; Flanigan J; Fleming KA; Kuti MA; Looi LM; Pai SA; Lawler M
Lancet; 2018 May; 391(10133):1953-1964. PubMed ID: 29550030
[TBL] [Abstract][Full Text] [Related]
13. Pathologists Overseas: A volunteer-based model for building sustainable, high-quality pathology and laboratory medicine services in low- and middle-income countries.
Glynn EH; Nelson AM; Tesfazghi M; Harb R; Amukele T
Front Med (Lausanne); 2022; 9():977840. PubMed ID: 36111111
[TBL] [Abstract][Full Text] [Related]
14. CORRUPTION IN MEDICAL PRACTICE: WHERE DO WE STAND?
Yousafzai AW
J Ayub Med Coll Abbottabad; 2015; 27(3):515-6. PubMed ID: 26720996
[TBL] [Abstract][Full Text] [Related]
15. Understanding medical corruption in China: a mixed-methods study.
Fu H; Lai Y; Li Y; Zhu Y; Yip W
Health Policy Plan; 2023 Apr; 38(4):496-508. PubMed ID: 36798965
[TBL] [Abstract][Full Text] [Related]
16. [Corruption and health care system].
Marasović Šušnjara I
Acta Med Croatica; 2014 Jun; 68(3):243-6. PubMed ID: 26016214
[TBL] [Abstract][Full Text] [Related]
17. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
[TBL] [Abstract][Full Text] [Related]
18. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
Griffore KA; Bowra A; Guilcher SJT; Kohler J
Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
[TBL] [Abstract][Full Text] [Related]
19. Access to pathology and laboratory medicine services: a crucial gap.
Wilson ML; Fleming KA; Kuti MA; Looi LM; Lago N; Ru K
Lancet; 2018 May; 391(10133):1927-1938. PubMed ID: 29550029
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
